# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Pulmonary arterial hypertension

Idiopathic pulmonary hypertensionPrimary pulmonary hypertension
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 228 results.
Positioning Imatinib for Pulmonary Arterial Hypertension
Status: Not yet recruiting
Last Changed: Sep 04, 2020
First Received: Jun 04, 2020
Disease(s): Pulmonary Arterial Hypertension
Intervention(s): Imatinib Mesylate
Locations: Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, Greater London, United Kingdom
Royal United Hospital, Royal United Hospitals Bath NHS Foundation Trust, Bath, United Kingdom
Royal Papworth Hospital, Royal Papworth Hospital NHS Foundation Trust, Cambridge, United Kingdom
Golden Jubilee National Hospital, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom
Royal Free Hospital, Royal Free London NHS Foundation Trust, London, United Kingdom
... and 4 other locations.
Acute Haemodynamic Study of TPN171H in Patients With Pulmonary Arterial Hypertension
Status: Not yet recruiting
Last Changed: Jul 23, 2020
First Received: Jul 23, 2020
Disease(s): Pulmonary Arterial Hypertension
Intervention(s): TPN171H, Placebo, Tadalafil
Locations: Peking Union Medical College Hospital, Beijing, Beijing, China
Peking University First Hospital, Beijing, Beijing, China
Fuwai Hospital CAMS&PUMC, Beijing, Beijing, China
The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing, China
The Second Xiangya Hospital of Central South University, Changsha, Hunan, China
... and 2 other locations.
BMPR2 Mutations and Iron Metabolism in Pulmonary Arterial Hypertension
Status: Recruiting
Last Changed: Sep 11, 2019
First Received: Sep 11, 2019
Disease(s): Pulmonary Arterial Hypertension
Intervention(s): hepcidin levels and BMPR2 expression
Locations: Centre for Pulmonary Hypertension at the Thoraxklinik, Heidelberg University Hospital, Heidelberg, Germany
Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study
Status: Recruiting
Last Changed: Aug 27, 2020
First Received: Aug 31, 2018
Disease(s): Pulmonary Arterial Hypertension
Intervention(s): Apabetalone
Locations: Peter Lougheed Center, Calgary, Alberta, Canada
IUCPQ-UL, Quebec City, Quebec, Canada
Reducing Right Ventricular Failure in Pulmonary Arterial Hypertension (RELIEVE-PAH)
Status: Recruiting
Last Changed: Aug 05, 2020
First Received: Feb 12, 2019
Disease(s): Pulmonary Arterial Hypertension
Intervention(s): V-Wave Interatrial Shunt
Locations: Keck Medical Center of USC, Los Angeles, California, United States
University of California, San Francisco, San Francisco, California, United States
The Ohio State University Wexner Medical Center - Davis Heart & Lung Research Institute, Columbus, Ohio, United States
Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Québec, Canada
Instituto Nacional de Cardiologia, Mexico City, Mexico
... and 1 other locations.
Pilot Study of the Safety and Efficacy of Sulfasalazine in Pulmonary Arterial Hypertension
Status: Recruiting
Last Changed: Aug 27, 2020
First Received: Aug 27, 2020
Disease(s): Pulmonary Arterial Hypertension
Intervention(s): Sulfasalazine, Ambrisentan, Sulfasalazine's placebo, Ambrisentan's placebo
Locations: Renji Hospital, Shanghai, China
A Study of Pulmonary Arterial Hypertension Participants Treated With Macitentan or Selexipag
Status: Not yet recruiting
Last Changed: Sep 30, 2020
First Received: Sep 28, 2020
Disease(s): Pulmonary Arterial Hypertension
Intervention(s): PAH medication
Locations: Policinico A Gemelli, Roma, Italy
A Study of GMA301 in Subjects With Pulmonary Arterial Hypertension
Status: Recruiting
Last Changed: Aug 07, 2020
First Received: Aug 07, 2020
Disease(s): Pulmonary Arterial Hypertension
Intervention(s): Q4W GMA301 IV injections (300 mg), Q4W GMA301 IV injections (600 mg), Q4W GMA301 IV injections (1000 mg), Q4W placebo IV injections
Locations: Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, United States
Brigham and Women's Hospital, Boston, Massachusetts, United States
The Ohio State University - Dorothy M. Davis Heart and Lung Research Institute, Louisville, Ohio, United States
The University of Texas Southwestern Medical Center, Dallas, Texas, United States
Peking Union Medical College Hospital - Dongcheng District, Beijing, China
... and 6 other locations.
A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension
Status: Recruiting
Last Changed: Mar 18, 2020
First Received: Nov 13, 2018
Disease(s): Pulmonary Arterial Hypertension
Intervention(s): Sotatercept
Locations: The University of Arizona, Tucson, Arizona, United States
Brigham and Women's Hospital, Boston, Massachusetts, United States
Mayo Clinic, Rochester, Minnesota, United States
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension
Status: Recruiting
Last Changed: Sep 30, 2020
First Received: Feb 18, 2020
Disease(s): Pulmonary Arterial Hypertension
Intervention(s): Macitentan 10 mg, Macitentan 37.5 mg, Macitentan 75 mg, Placebo
Locations: Arizona Pulmonary Specialists, Ltd, Phoenix, Arizona, United States
Mayo Clinic, Phoenix, Arizona, United States
Scripps Memorial Hospital, La Jolla, California, United States
USC Keck, Los Angeles, California, United States
Santa Barbara Pulmonary Associates, Santa Barbara, California, United States
... and 205 other locations.